Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
B7-33 and BAC Water Mix

B7-33 Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example B7-33 Titration Schedule

ItemDetails
Standard dose200–400 mcg once daily
Courses10–20 days, 2–3× per year
Originator dose10–1000× lower (Russian tradition)

No human trials; single-lab rodent pharmacology (relaxin B-chain analog). The '1–5 mg per dose' figure is a recurring placeholder that never matched a validated protocol for any bioregulator; sources disagree up to 1000× on real doses.

Possible vial strengths:

What Is It?

B7-33

Single-chain relaxin analogue.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix B7-33

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

B7-33 Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

B7-33 (CAS 1818415-56-3) is a 24-amino-acid single-chain peptide derived from the B-chain of the hormone H2 relaxin, designed as a simplified relaxin-2 analog. It acts as a "biased" agonist at the RXFP1 receptor, switching on relaxin's anti-fibrotic signaling while avoiding the pathway tied to its vascular and tumor-promoting effects. All evidence to date is preclinical — cells and rodents only.
In animal and cell studies, B7-33's main reported effect is reduced fibrosis (scarring) in heart, lung, and kidney tissue, achieved by triggering MMP-2 and breaking down excess collagen. Because it favors the pERK1/2 pathway over the cAMP route of full relaxin, researchers use it as a tool to study anti-scarring signaling without relaxin's proliferative effects. These are preclinical findings, not demonstrated outcomes in humans.
There is no established human dose for B7-33 — it has never been through human trials — so any figure is a research choice, not a recommendation. The reconstitution math itself is standard: a 5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL, so a 250 mcg amount = 0.1 mL (10 units on a U-100 insulin syringe). Larger water volumes give lower concentration and smaller draws for the same amount.
Native H2 relaxin (the recombinant drug serelaxin) is a complex two-chain, disulfide-linked molecule that is costly to make and whose cAMP signaling is linked to tumor-promoting effects — and serelaxin itself failed its phase 3 heart-failure trial. B7-33 was engineered as a single-chain shortcut that keeps the anti-fibrotic action while shedding that cAMP arm, making it cheaper to synthesize and cleaner mechanistically. So they are not interchangeable: serelaxin is full-length relaxin, B7-33 is a truncated biased agonist.
B7-33 is not approved anywhere — no FDA approval, no human safety data, and no clinical trials — so despite the strong anti-fibrotic reputation online, its profile in people is simply unknown. It is sold strictly as a research-grade compound, and "research-grade" is never the same as a tested medicine. Storage: keep the lyophilized powder refrigerated and protected from light, and use any reconstituted solution promptly rather than storing it long-term.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides